Published in J Exp Med on March 01, 1972
Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med (1979) 12.22
Interaction of aggregated -globulin with B lymphocytes. J Exp Med (1972) 9.29
Combined studies of complement receptor and surface immunoglobulin-bearing cells and sheep erythrocyte rosette-forming cells in normal and leukemic human lymphocytes. J Clin Invest (1973) 5.31
Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes. J Exp Med (1973) 5.03
A receptor for antibody on B lymphocytes. II. Immunochemical and electron microscopy characteristics. J Exp Med (1972) 4.63
Two different complement receptors on human lymphocytes. One specific for C3b and one specific for C3b inactivator-cleaved C3b. J Exp Med (1973) 4.46
The presence of two Fc receptors on mouse macrophages: evidence from a variant cell line and differential trypsin sensitivity. J Exp Med (1977) 3.55
Studies of the human lymphocyte receptor for heat-aggregated or antigen-complexed immunoglobulin. J Exp Med (1974) 3.39
Immunoglobulins cytophilic for human lymphocytes, monocytes, and neutrophils. J Clin Invest (1975) 3.39
Receptors for aggregated IgG on mouse lymphocytes: their presence on thymocytes, thymus-derived, and bone marrow-derived lymphocytes. J Exp Med (1974) 3.21
Mycobacterium. Bacteriol Rev (1977) 3.20
Evidence for identity or close association of the Fc receptor of B lymphocytes and alloantigens determined by the Ir region of the H-2 complex. J Exp Med (1974) 3.07
Activation of mouse lymphocytes by anti-immunoglobulin. I. Parameters of the proliferative response. J Exp Med (1978) 2.86
Characterizaiton of two populations of human lymphocytes bearing easily detectable surface immunoglobulin. J Clin Invest (1975) 2.78
Cell-to-cell interaction in the immune response. X. T-cell-dependent suppression in tolerant mice. J Exp Med (1974) 2.77
Cell interactions in the immune response in vitro. IV. Comparison of the effects of antigen-specific and allogeneic thymus-derived cell factors. J Exp Med (1972) 2.48
Growth of B-lymphocyte colonies in vitro. J Exp Med (1975) 2.41
Complement-dependent release of immune complexes from the lymphocyte membrane. J Exp Med (1973) 2.27
The Fc receptor on thymus-derived lymphocytes. I. Detection of a subpopulation of murine T lymphocytes bearing the Fc receptor. J Exp Med (1975) 2.15
Ontogeny of B lymphocytes. II. Relative rates of appearance of lymphocytes bearing surface immunoglobulin and complement receptors. J Exp Med (1974) 2.03
The role of antibody in T-cell responses. Clin Exp Immunol (1974) 1.67
Rosette formation by mouse lymphocytes. III. Receptors for immunoglobulin on normal and activated T cells. Clin Exp Immunol (1974) 1.59
Relationship between Fc receptors, antigen-binding sites on T and B cells, and H-2 complex-associated determinants. J Exp Med (1975) 1.58
Receptor for the fourth component of complement on human B lymphocytes and cultured human lymphoblastoid cells. J Exp Med (1974) 1.56
Inhibition of lymphocyte mitogenesis by immobilized antigen-antibody complexes. J Exp Med (1975) 1.55
Shedding and reappearance of Fc, C3 and SRBC receptors on peripheral lymphocytes from normal donors and chronic lymphatic leukaemia (CLL) patients. Immunology (1978) 1.51
B-lymphocytes activation by the Fc region of IgG. J Exp Med (1977) 1.51
Studies on the differentiation of B lymphocytes in the mouse. Immunology (1973) 1.46
Effect of B-cell mitogens on lymphocyte subpopulations possesing C'3 and Fc receptors. J Exp Med (1974) 1.46
Recirculating, suppressor T cells in transplantation tolerance. J Exp Med (1977) 1.43
Human peripheral lymphocytes bearing both B-cell complement receptors and T-cell characteristics for sheep erythrocytes detected by a mixed rosette method. Clin Exp Immunol (1974) 1.40
Generation of cytotoxic lymphocytes in mixed lymphocyte reactions. I. Specificity of the effector cells. J Exp Med (1973) 1.39
Identification of DNA-binding lymphocytes in patients with systemic lupus erythematosus. J Clin Invest (1975) 1.38
Cell surface immunoglobulin. VII. Synthesis, shedding, and secretion of immunoglobulin by lymphoid cells of germ-free mice. J Exp Med (1974) 1.38
Fc-receptors, Ia-antigens, and immunoglobulin on normal and activated mouse T lymphocytes. J Exp Med (1975) 1.32
Isolation and partial characterization of Fc gamma-binding proteins of human leukocytes. J Clin Invest (1981) 1.31
Immunocompetent cells in resistance to bacterial infections. Bacteriol Rev (1976) 1.31
Role of C'3 and Fc receptors in B-lymphocyte activation. J Exp Med (1975) 1.30
Malignant lymphomas--a conceptual understanding of morphologic diversity. A review. Am J Pathol (1979) 1.30
Hematopoietic thymocyte precursors: II. Properties of the precursors. J Exp Med (1977) 1.28
Restriction of gene expression in B lymphocytes and their progeny. II. Commitment to immunoglobulin heavy chain isotype. J Exp Med (1974) 1.25
Functional heterogeneity of murine lymphoid cells. V. Lymphocytes lacking detectable surface theta or immunoglobulin determinants. J Exp Med (1973) 1.22
Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b. Immunology (1978) 1.18
Induction of immunological tolerance to a thymus-dependent antigen in the absence of thymus-derived cells. J Exp Med (1974) 1.12
Cytotoxicity of human lymphocytes induced by rabbit antibodies to chicken erythrocytes. Inhibition by normal IgG and by human myeloma proteins of different IgG subclasses. Immunology (1973) 1.11
Lymphocytes in patients with variable immunodeficiency and panhypogammaglobulinemia. Evaluation of B and T cell surface markers and a proposed classification. J Clin Invest (1974) 1.11
Interaction of the hinge region of human immunoglobulin G with a murine lymphocyte membrane receptor. Relevance to the problem of antiglobulin induction in rheumatoid arthritis. Immunology (1975) 1.10
Regulation of the immune response. VI. Inability of F(ab') 2 antibody to terminate established immune responses and its ability to interfere with IgG antibody-mediated immunosuppression. Immunology (1973) 1.09
Different rosette assays for detecting Fc receptor-bearing lymphocytes measure different subpopulations. Immunology (1978) 1.00
Cellular immunology in the pig. Proc R Soc Med (1973) 1.00
Membrane receptor sites for the identification of lymphoreticular cells in benign and malignant conditions. Br J Cancer Suppl (1975) 0.99
A human leukemia cell with both B and T cell surface receptors. Proc Natl Acad Sci U S A (1974) 0.98
Inhibition of T- and B-lymphocyte functions by normal immunosuppressive protein. Immunology (1975) 0.98
Antigenic surface determinants of chicken lymphoid cells. I. Serologic properties of anti-bursa and anti-thymus sera. Clin Exp Immunol (1973) 0.97
Biochemical signal transmitted by Fc gamma receptors: phospholipase A2 activity of Fc gamma 2b receptor of murine macrophage cell line P388D1. Proc Natl Acad Sci U S A (1982) 0.97
Specific heterologous enhancement of immune responses. IV. Specific generation of a thymus-derived enhancing factor. J Exp Med (1972) 0.96
Human bone marrow lymphocytes. Cytotoxic effector cells in the bone marrow of normal individuals. J Clin Invest (1976) 0.95
Rosette formation by mouse lymphocytes. IV. Fc and C3 receptors occurring together and separately on T cells and other leucocytes. Clin Exp Immunol (1975) 0.95
Polyclonal activation to immunoglobulin secretion in human adenoid lymphocytes induced by bacteria from nasopharynx in vitro. Clin Exp Immunol (1978) 0.93
Surface T-and B-cell markers on murine lymphomas and plasmacytomas. Immunology (1974) 0.93
Lymphocytes binding basic protein of myelin; cytophilic serum antibody and effect of adjuvant. Immunology (1973) 0.92
Immunological studies of mouse decidual cells. I. Membrane markers of decidual cells in the days after implantation. J Exp Med (1978) 0.92
Antibody-dependent lymphocyte killer function in human immunodeficiency diseases. Clin Exp Immunol (1975) 0.92
Isolation and characterization of Fc-receptors shed from human peripheral mononuclear cells. Immunology (1978) 0.91
Characterization of human adenoid cells using surface and functional markers for lymphocyte subpopulations. Clin Exp Immunol (1977) 0.91
Properties of an Fc gamma-binding protein isolated from human leukemic B cells. J Exp Med (1979) 0.90
Impairement of thymus derived rosette forming cells during photochemotherapy (psoralen--U.V.A.). Arch Dermatol Res (1978) 0.90
Red cell Fc receptors and their participation in the passive haemagglutination mediated by non-precipitating antibodies. Immunology (1974) 0.89
Immunodeviation by passive antibody, an expression of selective immunodepression. II. Action of guinea pig IgG1 and IgG2 anticarrier antibodies. J Exp Med (1973) 0.88
Immunofluorescent staining of the surfaces of lymphocytes in suspension from patients with dengue hemorrhagic fever. Am J Pathol (1976) 0.88
Detection of non-H2 antigen(s) which, like Ia antigens, are associated with the Fc receptor of B lymphocytes. J Exp Med (1975) 0.88
Nonspecific stimulation of lymphocytes by tuberculin. Infect Immun (1977) 0.87
T and B lymphocytes in the marmoset: a natural haemopoietic chimera. Clin Exp Immunol (1976) 0.87
Rosette formation in rheumatiod and non-rheumatiod states. Ann Rheum Dis (1974) 0.87
Blood and thyroid-infiltrating lymphocyte subclasses in juvenile autoimmune thyroiditis. Clin Exp Immunol (1977) 0.86
Migration of newly formed small lymphocytes from bone marrow to lymph nodes during primary immune responses. Clin Exp Immunol (1976) 0.86
Surface antigenic specificities of human thymus-derived lymphocytes. Clin Exp Immunol (1975) 0.86
Lymphocyte receptors. I. Receptors for Fc of IgG and complement (C3b) on immunoglobulin-bearing, antigen-binding and antibody-secreting cells. Immunology (1976) 0.86
Inhibition of the Fc receptor of human lymphoid cells by antisera-recognizing determinants of the hla system. J Exp Med (1976) 0.86
The in vitro induction of immunological tolerance in the B lymphocyte by oligovalent thymus-dependent antigens. J Exp Med (1975) 0.85
T-cell and B-cell identification in the diagnosis of lymphoproliferative disease. A review. Am J Pathol (1977) 0.84
Immune complex receptors on cell surfaces. II. Cytochemical evaluation of their abundance on different immune cells: distribution, uptake, and regeneration. Am J Pathol (1976) 0.83
Dependence of phagocytosis on strength of phagocyte-particle interaction. Immunology (1978) 0.83
Distribution and properties of Fc receptors for IgG on different leucocyte populations in man. Clin Exp Immunol (1981) 0.83
Antibody isotypes mediating antigen retention in passively immunized mice. Immunology (1980) 0.83
Antigen heterogeneity of human B and T lymphocytes. J Clin Invest (1976) 0.83
Termination of aquired and natural immunological tolerance with specific complexes. J Exp Med (1975) 0.81
The incomplete anti-Rh antibody agglutination mechanism of trypsinized ORh+ red cells. Immunology (1977) 0.81
Evidence for a T-cell reaction in the cutaneous sarcoid granuloma. Arch Dermatol Res (1977) 0.81
Different divalent cation requirements for binding IgM complexes to lymphocytes and macrophages. J Exp Med (1980) 0.80
Mechanisms of suppression of the immune response. I. Differences in the effect of specific inhibitory antibody on distribution of 51CR-labelled sheep erythrocytes in different mouse strains. Immunology (1973) 0.80
Enhanced Fc receptor expression by a sub-population of murine intra-tumour macrophages following intravenous Corynebacterium parvum therapy. Br J Cancer (1983) 0.79
Release and reconstitution of Fc receptors from normal human mononuclear cells. Immunology (1980) 0.79
Cells and mediators which participate in immunoglobulin synthesis by human mononuclear cells. II. The mechanism of null cell participation in immunoglobulin synthesis and secretion by B cells. Clin Exp Immunol (1990) 0.78
Effects of cholera exotoxin on Fc receptor activity of lymphoid cells and mononuclear phagocytes. Immunology (1977) 0.78
Independent movement of surface immunoglobulin from Fc receptors on lymphocyte membranes. Immunology (1975) 0.78
The specificity of the Fc receptor on murine lymphocytes for immunoglobulins of the IgG and IgM classes. Immunology (1976) 0.77
EA rosette-forming lymphoid cells in chickens: specificity of the Fc receptor and its relationship to other surface antigens. Immunology (1976) 0.77
T and B lymphocytes in vitiligo. Arch Dermatol Res (1978) 0.75
Different immunosuppressive effects of anti-red blood cell sera and their fractions obtained from various animal species. Immunology (1973) 0.75
Plaque formation and isolation of pure lines with poliomyelitis viruses. J Exp Med (1954) 68.67
Further improvements in the plaque technique for detecting single antibody-forming cells. Immunology (1968) 24.83
A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization. J Exp Med (1970) 15.86
THE AKR THYMIC ANTIGEN AND ITS DISTRIBUTION IN LEUKEMIAS AND NERVOUS TISSUES. J Exp Med (1964) 13.72
ANTIGENS IN IMMUNITY. I. PREPARATION AND PROPERTIES OF FLAGELLAR ANTIGENS FROM SALMONELLA ADELAIDE. Aust J Exp Biol Med Sci (1964) 10.00
Cell to cell interaction in the immune response. I. Hemolysin-forming cells in neonatally thymectomized mice reconstituted with thymus or thoracic duct lymphocytes. J Exp Med (1968) 9.67
Immunoglobulins on the surface of lymphocytes. I. Distribution and quantitation. J Exp Med (1971) 8.22
An in vitro reaction between labelled flagellin or haemocyanin and lymphocyte-like cells from normal animals. Immunology (1969) 6.28
Contactual lysis of antibody-coated chicken erythrocytes by purified lymphocytes. Cell Immunol (1970) 5.10
A receptor for antibody on B lymphocytes. II. Immunochemical and electron microscopy characteristics. J Exp Med (1972) 4.63
Specific inactivation of thymus-derived (T) and non-thymus-derived (B) lymphocytes by 125I-labelled antigen. Nat New Biol (1971) 4.55
Antigens in immunity. 8. Localization of 125-I-labelled antigens in the secondary response. Immunology (1965) 4.00
Theta-bearing and complement-receptor lymphocytes are distinct populations of cells. Science (1971) 3.16
Antigens in immunity. XII. Antigen trapping in the spleen. Int Arch Allergy Appl Immunol (1966) 2.62
A simple and efficient method of separating peripheral-blood leucocytes for in-vitro studies. Lancet (1967) 2.38
Activation of thymus cells by histocompatibility antigens. Nat New Biol (1971) 2.26
Thymus-derived cells in mouse thoracic duct lymph. Nat New Biol (1971) 2.07
Thymus-derived lymphocytes: their distribution and role in the development of peripheral lymphoid tissues of the mouse. Eur J Immunol (1971) 2.03
The effect of antigenic stimulation on incorporation of phosphate and methionine into proteins of isolated lymph node cells. J Exp Med (1959) 2.03
The immune response of normal, irradiated and thymectomized mice to fowl immunoglobulin G as detected by a hemolytic plaque technique. Int Arch Allergy Appl Immunol (1971) 1.85
Failure of certain cytotoxic lymphocytes to respond mitotically to phytohaemagglutinin. Nature (1970) 1.62
Cell-to-cell interaction in the immune response. VII. Requirement for differentiation of thymus-derived cells. J Exp Med (1971) 1.46
Early 7S antibody--antigen complexes with affinity to spleen cells in chickens immunized with a low dose of human serum albumin. Immunology (1970) 1.13
Regulation of the immune response. II. Further studies on differences in ability of F(ab')2 and 7S antibodies to inhibit an antibody response. Immunology (1970) 1.13
Delayed hypersensitivity reactions in normal and bursectomized chickens. Int Arch Allergy Appl Immunol (1971) 1.11
Antigen binding and the immune response. II. The large number of antigen-binding cells in primed animals. Proc Soc Exp Biol Med (1970) 1.06
High efficiency transformation of E. coli by high voltage electroporation. Nucleic Acids Res (1988) 34.78
Cell to cell interaction in the immune response. II. The source of hemolysin-forming cells in irradiated mice given bone marrow and thymus or thoracic duct lymphocytes. J Exp Med (1968) 12.91
Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature (1998) 11.08
Cell to cell interaction in the immune response. I. Hemolysin-forming cells in neonatally thymectomized mice reconstituted with thymus or thoracic duct lymphocytes. J Exp Med (1968) 9.67
Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity (1998) 9.02
Thymus and antigen-reactive cells. Transplant Rev (1969) 8.84
Current concepts of the immunological function of the thymus. Physiol Rev (1967) 8.37
Turnover of naive- and memory-phenotype T cells. J Exp Med (1994) 8.07
Immunological activity of thymus and thoracic-duct lymphocytes. Proc Natl Acad Sci U S A (1968) 7.49
Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science (1996) 7.00
IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci U S A (2001) 6.91
Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell (1990) 6.33
T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature (1994) 6.20
A monoclonal antibody discriminating between subsets of T and B cells. J Immunol (1981) 6.15
The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity (1999) 6.10
Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med (1997) 5.72
Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med (1996) 5.21
Cell to cell interaction in the immune response. 3. Chromosomal marker analysis of single antibody-forming cells in reconstituted, irradiated, or thymectomized mice. J Exp Med (1968) 5.02
Sequences required for expression of Bordetella pertussis virulence factors share homology with prokaryotic signal transduction proteins. Proc Natl Acad Sci U S A (1989) 4.78
A receptor for antibody on B lymphocytes. II. Immunochemical and electron microscopy characteristics. J Exp Med (1972) 4.63
Specific inactivation of thymus-derived (T) and non-thymus-derived (B) lymphocytes by 125I-labelled antigen. Nat New Biol (1971) 4.55
Mechanism of eosinophilia. II. Role of the lymphocyte. J Exp Med (1970) 4.34
Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature (1991) 4.04
Induction of self-tolerance in mature peripheral B lymphocytes. Nature (1989) 4.02
Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J Exp Med (1997) 4.01
Antigens in immunity. 8. Localization of 125-I-labelled antigens in the secondary response. Immunology (1965) 4.00
The thymus and the precursors of antigen reactive cells. Nature (1967) 3.92
Role of major histocompatibility complex gene products in delayed-type hypersensitivity. Proc Natl Acad Sci U S A (1976) 3.69
Cellular basis of the immunological defects in thymectomized mice. Nature (1967) 3.69
Ectopic expression of the flagellar regulon alters development of the Bordetella-host interaction. Cell (1995) 3.64
Circulating T and B lymphocytes of the mouse. I. Migratory properties. Cell Immunol (1973) 3.53
Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow. J Exp Med (1978) 3.46
BvgAS-mediated signal transduction: analysis of phase-locked regulatory mutants of Bordetella bronchiseptica in a rabbit model. Infect Immun (1994) 3.44
Mechanism of eosinophilia. I. Factors affecting the eosinophil response of rats to Trichinella spiralis. J Exp Med (1970) 3.40
Antigen-induced selective recruitment of circulating lymphocytes. Cell Immunol (1971) 3.35
H-2 gene complex restricts transfer of delayed-type hypersensitivity in mice. Proc Natl Acad Sci U S A (1975) 3.34
Regeneration of thymus grafts. I. Histological and cytological aspects. Transplantation (1965) 3.29
Quantitative features of a sandwich radioimmunolabeling technique for lymphocyte surface receptors. J Exp Med (1972) 3.28
Roles for motility in bacterial-host interactions. Mol Microbiol (1997) 3.16
Cell to cell interaction in the immune response. IV. Site of action of antilymphocyte globulin. J Exp Med (1968) 3.16
Cell-to-cell interaction in the immune response. VI. Contribution of thymus-derived cells and antibody-forming cell precursors to immunological memory. J Exp Med (1971) 3.14
Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell (1993) 3.09
T cell-dependent suppression of an anti-hapten antibody response. Transplant Rev (1975) 3.06
Interaction between lymphocytes in immune responses. Cell Immunol (1971) 3.03
Collaboration of histoincompatible T and B lymphocytes using cells from tetraparental bone marrow chimeras. J Exp Med (1975) 3.03
Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression. J Exp Med (1976) 3.00
T cell priming in vivo: a major role for B cells in presenting antigen to T cells in lymph nodes. J Immunol (1987) 2.93
Early embryonic mortality in women. Fertil Steril (1982) 2.92
Reentry of T cells to the adult thymus is restricted to activated T cells. J Exp Med (1991) 2.81
Properties of purified T cell subsets. I. In vitro responses to class I vs. class II H-2 alloantigens. J Exp Med (1985) 2.79
Cell-to-cell interaction in the immune response. X. T-cell-dependent suppression in tolerant mice. J Exp Med (1974) 2.77
Fetal loss after implantation. A prospective study. Lancet (1980) 2.73
TCR-Mediated internalization of peptide-MHC complexes acquired by T cells. Science (1999) 2.70
Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes. Nature (1991) 2.67
Screening for receptor ligands using large libraries of peptides linked to the C terminus of the lac repressor. Proc Natl Acad Sci U S A (1992) 2.67
Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity. Proc Natl Acad Sci U S A (1995) 2.66
A radioisotopic method to measure delayed type hypersensitivity in the mouse. I. Studies in sensitized and normal mice. Int Arch Allergy Appl Immunol (1975) 2.64
Antigens in immunity. XII. Antigen trapping in the spleen. Int Arch Allergy Appl Immunol (1966) 2.62
Compartmentalization of bacterial antigens: differential effects on priming of CD8 T cells and protective immunity. Cell (1998) 2.59
A defect in central tolerance in NOD mice. Nat Immunol (2001) 2.59
Type I interferon-mediated stimulation of T cells by CpG DNA. J Exp Med (1998) 2.58
Homeostatic T cell proliferation: how far can T cells be activated to self-ligands? J Exp Med (2000) 2.55
CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J Exp Med (1997) 2.49
Cell interactions in the immune response in vitro. IV. Comparison of the effects of antigen-specific and allogeneic thymus-derived cell factors. J Exp Med (1972) 2.48
Diabetes in transgenic mice resulting from over-expression of class I histocompatibility molecules in pancreatic beta cells. Nature (1988) 2.46
Integration of multiple domains in a two-component sensor protein: the Bordetella pertussis BvgAS phosphorelay. EMBO J (1996) 2.41
Growth of B-lymphocyte colonies in vitro. J Exp Med (1975) 2.41
Mycobacterium leprae antigens involved in human immune responses. I. Identification of four antigens by monoclonal antibodies. J Immunol (1985) 2.40
Association of immunity and tolerance to host H-2 determinants in irradiated F1 hybrid mice reconstituted with bone marrow cells from one parental strain. J Exp Med (1975) 2.39
Peripheral deletion of self-reactive B cells. Nature (1991) 2.34
The bvgAS locus negatively controls motility and synthesis of flagella in Bordetella bronchiseptica. J Bacteriol (1992) 2.33
The bvgA gene of Bordetella pertussis encodes a transcriptional activator required for coordinate regulation of several virulence genes. J Bacteriol (1989) 2.29
Tolerance to histocompatibility determinants in tetraparental bone marrow chimeras. J Exp Med (1975) 2.29
T cell stimulation in vivo by lipopolysaccharide (LPS). J Exp Med (1997) 2.29
Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences. J Exp Med (1986) 2.29
Activation of thymus cells by histocompatibility antigens. Nat New Biol (1971) 2.26
The role of the thymus and recent thymic migrants in the maintenance of the adult peripheral lymphocyte pool. J Exp Med (1998) 2.25
Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J Exp Med (1998) 2.24
Growth of B lymphocyte colonies in vitro from mouse lymphoid organs. Nature (1975) 2.24
Tolerance of class I histocompatibility antigens expressed extrathymically. Nature (1989) 2.19
Restricted helper function of F1 leads to parent bone marrow chimeras controlled by K-end of H-2 complex. J Exp Med (1978) 2.17
MICROBIOME. A unified initiative to harness Earth's microbiomes. Science (2015) 2.15
Reduced life span of anergic self-reactive B cells in a double-transgenic model. J Exp Med (1994) 2.15
Enrichment of specific suppressor T cells and characterization of their surface markers. J Exp Med (1977) 2.13
Identity of cells that imprint H-2-restricted T-cell specificity in the thymus. Nature (1986) 2.11
Thymus-derived cells in mouse thoracic duct lymph. Nat New Biol (1971) 2.07
A mutation in the Bordetella bronchiseptica bvgS gene results in reduced virulence and increased resistance to starvation, and identifies a new class of Bvg-regulated antigens. Mol Microbiol (1997) 2.01